CRDL
Cardiol Therapeutics Inc Class A
NASDAQ: CRDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.38
+5.34% today
Updated 2026-04-30
Market cap
$156.35M
P/E ratio
—
P/S ratio
1,014.87x
EPS (TTM)
$-0.29
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
Cardiol Therapeutics Inc Class A (CRDL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-158.70%
ROA
-77.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-1.66M | — | — | — |
| 2018 | $0.00 | $-15.89M | — | — | — |
| 2019 | $0.00 | $-10.55M | — | — | — |
| 2020 | $78760.00 | $-16.20M | -228.76% | -20,620.30% | -20,570.94% |
| 2021 | $62267.00 | $-25.01M | -179.87% | -49,092.44% | -40,170.87% |
| 2022 | $0.00 | $-22.82M | — | — | — |
| 2023 | $0.00 | $-21.22M | — | — | — |
| 2024 | $0.00 | $-36.68M | — | — | — |
| 2025 | $0.00 | $-33.82M | — | — | — |